Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



AstraZeneca Faces Investigation by Chinese Authorities

December 12, 2024
AstraZeneca PLC (AZN) shares experienced a decline in value following reports of a probe by the People's Republic of China (PRC). The investigation is centered around alleged fraud and corruption within the company. The news has disappointed investors and raised concerns about AstraZeneca's operations in China. With 86% ownership of the shares, AstraZeneca is heavily controlled by institutional owners. Investors are recommended to seek guidance from professionals at Stocks Prognosis to determine the future movement of the company's shares.
If you want to leave a comment, then you need Login or Register





Other data for AZN

Related data

AZNSeptember 3, 2025ASTRAZENECA PLC Hits QuantWave Forecast, Generating 16.24% Profit  ~2 min.

ASTRAZENECA PLC has successfully reached the price target forecasted by QuantWave on July 11, 2025. The forecast indicated a long position with a price of 70.64 $....


AZNSeptember 3, 2025ASTRAZENECA PLC Hits 11.81% Profit Target as Forecasted by QuantWave  ~1 min.

ASTRAZENECA PLC's stock has successfully reached the price target forecasted by QuantWave, resulting in a profit of 11.81%. The forecast signal was given on 2025-08-01 when the stock was trading at 73....


AZNSeptember 3, 2025ASTRAZENECA PLC Stock Hits QuantWave Price Target with Profit of 19.38%  ~1 min.

On July 17, 2025, QuantWave, the automated forecasting platform, issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.78 $....


AZNSeptember 3, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 17.98% Profit  ~1 min.

On July 16, 2025, QuantWave's automated forecasting platform issued a signal for ASTRAZENECA PLC, predicting a long position with the stock trading at $69.6....


AZNAugust 25, 2025AstraZeneca's Breakthrough Study on Advanced Biliary Tract Cancer  ~1 min.

AstraZeneca PLC has recently announced groundbreaking results from their new study on advanced biliary tract cancer, showing promising potential for a new treatment option in cancer care....


AZNAugust 22, 2025ASTRAZENECA PLC Hits Price Target Forecast with 20.55% Profit  ~1 min.

On January 23, 2025, QuantWave issued a long signal for ASTRAZENECA PLC with a price of 67.17 $. The forecast proved to be accurate as the stock reached the target price of 80....


AZNAugust 22, 2025ASTRAZENECA PLC Stock Hits QuantWave's Price Target Forecast with 14.63% Profit  ~1 min.

ASTRAZENECA PLC stock has successfully reached the price target forecast provided by QuantWave, resulting in a profitable outcome for investors....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Price Target, Yielding 14.58% Profit - QuantWave Prediction Success  ~2 min.

On June 18, 2025, QuantWave issued a long forecast signal for ASTRAZENECA PLC when the stock was trading at $70.27....


AZNAugust 20, 2025ASTRAZENECA PLC Hits Price Target Forecast with 16.44% Profit: A Win for QuantWave  ~1 min.

ASTRAZENECA PLC, one of the leading pharmaceutical companies, has seen its stock price hit the forecasted target with a substantial 16....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Price Target, Generating 13.99% Profit for QuantWave Users  ~2 min.

On July 2, 2025, QuantWave, an automated forecasting platform, issued a price target forecast for ASTRAZENECA PLC with a long signal at a price of 70.64 $....


AZNDecember 10, 2024AstraZeneca PLC: A Leading Pharmaceutical Company with Strong Momentum  ~2 min.

AstraZeneca PLC (AZN) is a renowned pharmaceutical company that has been experiencing strong momentum in the market....


AZNDecember 13, 2024Hagens Berman Advisory Resource Group Makes New $946,000 Investment in AstraZeneca PLC  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently received a significant investment from Hagens Berman Advisory Resource Group in the amount of $946,000....


AZNNovember 10, 2024AstraZeneca PLC AZN: A Company on the Rise, Stocks Prognosis Recommends Buying  ~2 min.

AstraZeneca PLC (AZN), a global biopharmaceutical company, is steadily climbing the success ladder, and Stocks Prognosis recommends taking advantage of this upward trend by investing in their stocks....


AZNNovember 4, 2024AstraZeneca Announces Share Capital Details - Stocks Prognosis Recommends Buying AZN Shares  ~2 min.

AstraZeneca PLC, a renowned pharmaceutical company, recently revealed its share capital details. This news has attracted the attention of investors worldwide....


AZNDecember 21, 2024AstraZeneca Faces Investigation by Chinese Regulator, Shares Decline  ~1 min.

AstraZeneca PLC (AZN) shares have experienced a significant drop after reports emerged of a probe by the People's Republic of China (PRC) regarding alleged fraud and corruption....